BAG, URINAL

The contract solicitation SPE2DH-26-T-5810 seeks the procurement of absorbent urinal bags in packages of twenty, intended to replace traditional plastic urinals in medical settings. The product suppresses odors, facilitates measurement of diuresis and analysis, and eliminates the need for cleaning associated with reusable urinals. The item is identified by NSN 6530-01-608-6210 and is regulated by the FDA as a Class I medical device, requiring compliance with registration, listing, labeling, and GMP requirements, even though a 510(k) submission is not mandated. The supplier must be registered with a valid CAGE code 1Y3X1 and comply with all applicable medical marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129 for this medical acquisition. Packaging must align with MIL-STD-2073-1E and DLA Packaging Requirements RP001, with all units sealed in commercial containers designed to protect contents during transit and ensure safe, cost-effective delivery to the designated destination. Marking must include barcodes per MMS No. 1 and hazard labels compliant with OSHA’s Hazard Communication Standard, with any alternative labeling under other federal statutes explicitly documented. The contract requires delivery of two packages to the destination in APO AE 09227-0000, with freight shipped to Kaiserslautern, Germany, under FOB Destination terms, meaning the contractor bears all costs and risks until delivery. Delivery must be completed within 84 days of contract award, with zero variance allowed in quantity. Inspection and acceptance occur at the destination point, governed by FAR 52.246-2 and other referenced standards. Invoicing must be conducted through Wide Area WorkFlow (WAWF), and the contractor must submit all representations and certifications, including Unique Entity ID and CAGE code, and affirmatively disclose if any equipment involves covered defense telecommunications. The solicitation applies various FAR and DFARS clauses concerning equal opportunity, trafficking in persons, employment eligibility, sustainable products, cybersecurity safeguards, and whistleblower protections, with several clauses subject to deviation under agency waiver. The contract is part of a simplified acquisition under DLA’s automated procurement framework, with proposals required to be submitted electronically through DIBBS by the deadline of August 12, 2026.